miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms. Mayer MC, Berg JL, Perfler B, Hatzl S, et al. Ann Hematol 2021;100:2845-2847.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mayer MC, Berg JL, Perfler B, Hatzl S, et al. miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms. Ann Hematol 2021;100:2845-2847.
PMID: 34291333